Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations

被引：8
|
作者：
Claudiani, Simone [1 ,2 ]
Apperley, Jane F. [1 ,2 ]
Khan, Afzal [2 ]
Khorashad, Jamshid [2 ]
Milojkovic, Dragana [1 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Haematol, London, England
[2] Imperial Coll London, Hammersmith Hosp, Dept Immun & Inflammat, Ctr Haematol,Fac Med, London, England
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 05期
关键词：
MOLECULAR RESPONSE; CLINICAL-PRACTICE; INHIBITORS; IMATINIB; DISCONTINUATION; RECOMMENDATIONS; GUIDELINES; DASATINIB;
D O I：
10.3324/haematol.2019.234179
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E225 / E227
页数：3
相关论文
共 50 条
  • [31] A Retrospective Analysis of BCR-ABL1 Kinase Domain Mutations in the Frontline Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients: An Indian Experience from a High-End Referral Laboratory
    Majumdar, Atreye
    Katara, Rahul
    Mishra, Avshesh
    Gupta, Aastha
    Sharma, Deepak K.
    Srivastava, Aman K.
    Sharma, Shivani
    Jaiswal, Ankita
    Dixit, Mallika
    Kumar, Vipin
    Kumar, Sachin
    Kumar, Varun
    Sharma, Rahul
    Mohanty, Sambit K.
    SOUTH ASIAN JOURNAL OF CANCER, 2024, 13 (02) : 132 - 141
  • [32] Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study
    Abu Seman, Zahidah
    Ahid, Fadly
    Kamaluddin, Nor Rizan
    Sahid, Ermi Neiza Mohd
    Esa, Ezalia
    Said, Siti Shahrum Muhamed
    Azman, Norazlina
    Mat, Wan Khairull Dhalila Wan
    Abdullah, Julia
    Ali, Nurul Aqilah
    Khalid, Mohd Khairul Nizam Mohd
    Yusoff, Yuslina Mat
    BMC RESEARCH NOTES, 2024, 17 (01)
  • [33] ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia in Jordan
    Awidi, Abdalla
    Ababneh, Nidaa
    Magablah, Ahmad
    Bsoul, Nazzal
    Mefleh, Razan
    Marei, Lina
    Abbasi, Salah
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (11) : 1317 - 1321
  • [34] Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia
    Ureshino, Hiroshi
    Kamachi, Kazuharu
    Kimura, Shinya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (12) : 785 - 790
  • [35] Effect of BCR::ABL1 transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitor
    Park, Hyunkyung
    Kim, Hyeong-Joon
    Sohn, Sang-Kyun
    Baik, Yoonsuk
    Kim, Dongho
    Lee, Sung-Yeoun
    Kong, Jee Hyun
    Kim, Hawk
    Shin, Dong-Yeop
    Ahn, Jae-Sook
    Park, Jinny
    Park, Seonyang
    Kim, Inho
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [36] Treatment-free remission in chronic myeloid leukemia: floating between expectation and evidence
    Baccarani, M.
    LEUKEMIA, 2017, 31 (04) : 1015 - 1016
  • [37] Impact of BCR-ABL mutations on patients with chronic myeloid leukemia
    Hochhaus, Andreas
    La Rosee, Paul
    Mueller, Martin C.
    Ernst, Thomas
    Cross, Nicholas C. P.
    CELL CYCLE, 2011, 10 (02) : 250 - 260
  • [38] Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia
    El Missiry, Mohamed
    Hjorth-Hansen, Henrik
    Richter, Johan
    Olson-Stromberg, Ulla
    Stenke, Leif
    Porkka, Kimmo
    Kreutzman, Anna
    Mustjoki, Satu
    PLOS ONE, 2017, 12 (01):
  • [39] Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia
    Krumbholz, Manuela
    Karl, Matthias
    Tauer, Josephine T.
    Thiede, Christian
    Rascher, Wolfgang
    Suttorp, Meinolf
    Metzler, Markus
    GENES CHROMOSOMES & CANCER, 2012, 51 (11) : 1045 - 1053
  • [40] Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients
    Arun, A. K.
    Senthamizhselvi, A.
    Mani, S.
    Vinodhini, K.
    Janet, N. B.
    Lakshmi, K. M.
    Abraham, A.
    George, B.
    Srivastava, A.
    Srivastava, V. M.
    Mathews, V.
    Balasubramanian, P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (03) : 235 - 242
12345